Evidence map›Paper›PMID 39670162›Full record

ReviewRSC advances2024

Cancer treatment approaches within the frame of hyperthermia, drug delivery systems, and biosensors: concepts and future potentials.

Zeinab S Sayed, Eman M Hieba, Hany A Batakoushy, Huda R M Rashdan, Enas Ismail, Saeid M Elkatlawy, Amir Elzwawy

Erratum issuedAbstract readReview
In one paragraph

Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Zeinab S SayedFaculty of Applied Medical Science, Misr University for Science and Technology (MUST) Giza Egypt.ORCID https://orcid.org/0000-0003-3305-4577
Eman M HiebaChemistry and Entomology Department, Faculty of Science, Cairo University Giza 12613 Egypt.
Hany A BatakoushyDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Menoufia University Shebin Elkom 32511 Egypt.ORCID https://orcid.org/0000-0002-9958-4290
Huda R M RashdanChemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre 33 El Buhouth St., Dokki Giza 12622 Egypt Hudadawoud20@yahoo.com.ORCID https://orcid.org/0000-0001-7474-1678
Enas IsmailDepartment of Prosthodontics, Faculty of Dentistry, University of the Western Cape Cape Town 7505 South Africa.ORCID https://orcid.org/0000-0003-2538-6512
Saeid M ElkatlawyDepartment of Physics, Faculty of Science, University of Sadat City Fifth Zone Sadat Egypt.ORCID https://orcid.org/0000-0002-3919-8478
Amir ElzwawyCeramics Department, Advanced Materials Technology and Mineral Resources Research Institute, National Research Centre (NRC) 33 El Bohouth St., Dokki Giza 12622 Egypt elzwawy1@gmail.com aa.elzwawy@nrc.sci.eg.ORCID https://orcid.org/0000-0003-2206-1616

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work presents a review of the therapeutic modalities and approaches for cancer treatment. A brief overview of the traditional treatment routes is presented in the introduction together with their reported side effects. A combination of the traditional approaches was reported to demonstrate an effective therapy until a few decades ago. With the improvement in the fabrication of nanomaterials, targeted therapy represents a novel therapeutic approach. This improvement established on nanoparticles is categorized into hyperthermia, drug delivery systems, and biosensors. Hyperthermia presents a personalized medicine-based approach in which targeted zones are heated up until the diseased tissue is destroyed by the thermal effect. The use of magnetic nanoparticles further improved the effectiveness of hyperthermia owing to the enhanced heating action, further increasing the accuracy of the targeting process. Nanoparticle-based biosensors present a smart nanodevice that can detect, monitor, and target tumor tissues by following the biomarkers in the body fluids. Magnetic nanoparticles offer a controlled thermo-responsive device that can be manipulated by changing the magnetic field, offering a more personalized and controlled hyperthermia therapeutic modality. Similarly, gold nanoparticles offer an effective aid in the hyperthermia treatment approach. Furthermore, carbon nanotubes and metal-organic frameworks present a cutting-edge approach to cancer treatment. A combination of functionalized nanoparticles offers a unique route for drug delivery systems, in which therapeutic agents carried by nanoparticles are guided into the human body and then released in the target spot.

Identifiers

PMID39670162
PMCPMC11635600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.